Oregon Health & Science University researchers reported a previously unrecognized role for MYC in DNA repair processes that cancer cells use to survive genotoxic stress. The findings link the cancer-driving protein MYC to the DNA damage response, offering additional mechanistic context for why MYC-dependent tumors can resist cytotoxic or DNA-damaging therapies.